Clinscience
EN
DE PL FR
MENU
X
⤺
A positive decision for BIOOPA study announcements

A positive decision for BIOOPA study

At the beginning of October the Polish Competent Authority, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products gave permission for conducting the BIOOPA clinical. READ MORE
What are the new possibilities to help patients with melanoma? articles

What are the new possibilities to help patients with melanoma?

Melanoma is one of the most dangerous oncological diseases and although it accounts for only 4% of all dermatologic cancers, it is responsible for 80% of deaths from skin cancer. Study results have shown that only 14% of patients with metastatic melanoma survive for five years or more. READ MORE
Clinscience joins forces with Experior to underpin the strong position on the European clinical trials market announcements

Clinscience joins forces with Experior to underpin the strong position on the European clinical trials market

Following investments in Germany and Ukraine, the NEUCA Capital Group, through its subsidiary Clinscience, increases its CRO coverage by one of the largest clinical trials markets in Europe - Spain. By investing in Experior (100% shares), over a dozen million patients, develop competences in biostatistics, and expand this business area with new technological solutions. READ MORE
Clinscience successful in organising the adoption of TheraSphere® across hospitals in Poland announcements

Clinscience successful in organising the adoption of TheraSphere® across hospitals in Poland

Clinscience a global contract research organisation, today announced the successful adoption of TheraSphere by the Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice branch (Centrum Onkologii - Instytut, im. Marii Skłodowskiej-Curie Gliwice), Poland. READ MORE
What are the new possibilities to help patients with MDD? articles

What are the new possibilities to help patients with MDD?

Major depressive disorder (MDD) in adolescents is a commonly occurring seriously impairing and often undertreated disorder. READ MORE
A word about CAR-T Cells articles

A word about CAR-T Cells

CAR-T cells are the T-cells that have been genetically engineered to produce an artificial T-cell receptor for use in immunotherapy. READ MORE
About Us
Meet the Team Our Mission Our Values Our Customers
Services
Clinical Development Clinical Operations Biostatistics and Data Management Regulatory Pharmacovigilance Clinical Quality Temporary Resourcing Solutions Real-World Evidence Market Access
Therapeutic Area Expertise
Oncology & Haematology Orthopaedics & Wound Healing Central Nervous System (CNS) Women’s & Male Health Immunology and Cancer Immunotherapy Respiratory Medicine Cardiovascular Dermatology Metabolic & Endocrinology Biosimilars Rare & Orphan Disease Gastroenterology Ophthalmology Infectious Diseases
Newsroom Announcements Blog Articles
Join Us Contact Request for proposal Request for information